10 20 30 40 50 60 70 80 2D09 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXIDOREDUCTASE 30-JUL-05 2D09
TITLE A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF TITLE 2 SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE CYTOCHROME P450; COMPND 3 CHAIN: A; COMPND 4 EC: 1.14.-.-; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES COELICOLOR; SOURCE 3 ORGANISM_TAXID: 100226; SOURCE 4 STRAIN: A3(2); SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HMS174(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET17B
KEYWDS STREPTOMYCES, CYTOCHROME P450 OXIDOREDUCTASE, CYP158A2, PROTON KEYWDS 2 TRANSFER, DIOXYGEN ACTIVATION, OXIDOREDUCTASE
EXPDTA X-RAY DIFFRACTION
AUTHOR B.ZHAO,M.R.WATERMAN
REVDAT 4 13-JUL-11 2D09 1 VERSN REVDAT 3 24-FEB-09 2D09 1 VERSN REVDAT 2 17-JAN-06 2D09 1 JRNL REVDAT 1 25-OCT-05 2D09 0
JRNL AUTH B.ZHAO,F.P.GUENGERICH,M.VOEHLER,M.R.WATERMAN JRNL TITL ROLE OF ACTIVE SITE WATER MOLECULES AND SUBSTRATE HYDROXYL JRNL TITL 2 GROUPS IN OXYGEN ACTIVATION BY CYTOCHROME P450 158A2: A NEW JRNL TITL 3 MECHANISM OF PROTON TRANSFER JRNL REF J.BIOL.CHEM. V. 280 42188 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 16239228 JRNL DOI 10.1074/JBC.M509220200
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.ZHAO,F.P.GUENGERICH,A.BELLAMINE,D.C.LAMB,M.IZUMIKAWA, REMARK 1 AUTH 2 L.LEI,L.M.PODUST,M.SUNDARAMOORTHY,J.A.KALAITZIS,L.M.REDDY, REMARK 1 AUTH 3 S.L.KELLY,B.S.MOORE,D.STEC,M.VOEHLER,J.R.FALCK,T.SHIMADA, REMARK 1 AUTH 4 M.R.WATERMAN REMARK 1 TITL BINDING OF TWO FLAVIOLIN SUBSTRATE MOLECULES, OXIDATIVE REMARK 1 TITL 2 COUPLING, AND CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR REMARK 1 TITL 3 A3(2) CYTOCHROME P450 158A2 REMARK 1 REF J.BIOL.CHEM. V. 280 11599 2005 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 15659395 REMARK 1 DOI 10.1074/JBC.M410933200
REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 83.9 REMARK 3 NUMBER OF REFLECTIONS : 31890 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.400 REMARK 3 FREE R VALUE TEST SET COUNT : 3174 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.88 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE : 0.2170 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 265 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3102 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 75 REMARK 3 SOLVENT ATOMS : 258 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.27300 REMARK 3 B22 (A**2) : -0.08200 REMARK 3 B33 (A**2) : -1.19200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 49.90 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : HEMOXY.PARAM REMARK 3 PARAMETER FILE 3 : FLAV.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2D09 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-AUG-05. REMARK 100 THE RCSB ID CODE IS RCSB024826.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95 REMARK 200 MONOCHROMATOR : SI 220 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER PROTEUM 225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : HKL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35918 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 37.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : 0.10400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.35200 REMARK 200 R SYM FOR SHELL (I) : 0.33600 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: STRUCTURE REFINEMENT WITH REMARK 200 STARTING MODEL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1T93 REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, FLAVIOLIN, PH 6.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.50000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.47500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.46750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.47500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.50000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.46750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 GLU A 3
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 4 CG CD OE1 OE2 REMARK 470 SER A 180 OG REMARK 470 ARG A 206 CG CD NE CZ NH1 NH2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND HEM A 430 O2 OXY A 433 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 16 77.93 -111.80 REMARK 500 ASP A 76 -85.91 -56.59 REMARK 500 ARG A 77 -171.64 -69.65 REMARK 500 PRO A 98 -65.30 -9.91 REMARK 500 PRO A 99 -78.20 -43.06 REMARK 500 PRO A 140 -75.65 -26.74 REMARK 500 PRO A 141 106.23 -35.80 REMARK 500 VAL A 148 -48.13 -138.62 REMARK 500 SER A 180 61.27 -61.30 REMARK 500 SER A 181 -0.86 54.90 REMARK 500 SER A 182 -41.92 62.37 REMARK 500 ALA A 185 -147.33 172.80 REMARK 500 GLU A 186 19.02 -153.42 REMARK 500 ARG A 206 -51.11 60.58 REMARK 500 ASP A 208 40.30 -74.36 REMARK 500 SER A 209 -127.42 -149.97 REMARK 500 ALA A 290 -132.72 49.76 REMARK 500 ARG A 338 121.72 -14.28 REMARK 500 SER A 339 -126.66 -24.19 REMARK 500 ASN A 341 90.20 21.57 REMARK 500 LYS A 389 114.88 -39.23 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 703 DISTANCE = 5.97 ANGSTROMS
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 430 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 353 SG REMARK 620 2 HEM A 430 NA 101.4 REMARK 620 3 HEM A 430 NB 87.7 90.7 REMARK 620 4 HEM A 430 NC 80.2 178.4 89.5 REMARK 620 5 HEM A 430 ND 94.1 90.0 177.9 89.8 REMARK 620 6 OXY A 433 O2 153.9 95.8 111.7 82.7 66.2 REMARK 620 7 OXY A 433 O1 163.7 94.7 90.0 83.7 87.9 21.8 REMARK 620 N 1 2 3 4 5 6
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 430 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLV A 431 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLV A 432 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OXY A 433
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1T93 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH TWO MOLECULES OF FLAVIOLIN REMARK 900 RELATED ID: 1SE6 RELATED DB: PDB REMARK 900 FREE FORM OF THE SAME PROTEIN REMARK 900 RELATED ID: 1S1F RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 4-PHENYLIMIDAZOLE
DBREF 2D09 A 1 404 UNP Q9FCA6 Q9FCA6_STRCO 1 404
SEQADV 2D09 ALA A 405 UNP Q9FCA6 CLONING ARTIFACT SEQADV 2D09 ALA A 406 UNP Q9FCA6 CLONING ARTIFACT SEQADV 2D09 ALA A 407 UNP Q9FCA6 CLONING ARTIFACT
SEQRES 1 A 407 MET THR GLU GLU THR ILE SER GLN ALA VAL PRO PRO VAL SEQRES 2 A 407 ARG ASP TRP PRO ALA VAL ASP LEU PRO GLY SER ASP PHE SEQRES 3 A 407 ASP PRO VAL LEU THR GLU LEU MET ARG GLU GLY PRO VAL SEQRES 4 A 407 THR ARG ILE SER LEU PRO ASN GLY GLU GLY TRP ALA TRP SEQRES 5 A 407 LEU VAL THR ARG HIS ASP ASP VAL ARG LEU VAL THR ASN SEQRES 6 A 407 ASP PRO ARG PHE GLY ARG GLU ALA VAL MET ASP ARG GLN SEQRES 7 A 407 VAL THR ARG LEU ALA PRO HIS PHE ILE PRO ALA ARG GLY SEQRES 8 A 407 ALA VAL GLY PHE LEU ASP PRO PRO ASP HIS THR ARG LEU SEQRES 9 A 407 ARG ARG SER VAL ALA ALA ALA PHE THR ALA ARG GLY VAL SEQRES 10 A 407 GLU ARG VAL ARG GLU ARG SER ARG GLY MET LEU ASP GLU SEQRES 11 A 407 LEU VAL ASP ALA MET LEU ARG ALA GLY PRO PRO ALA ASP SEQRES 12 A 407 LEU THR GLU ALA VAL LEU SER PRO PHE PRO ILE ALA VAL SEQRES 13 A 407 ILE CYS GLU LEU MET GLY VAL PRO ALA THR ASP ARG HIS SEQRES 14 A 407 SER MET HIS THR TRP THR GLN LEU ILE LEU SER SER SER SEQRES 15 A 407 HIS GLY ALA GLU VAL SER GLU ARG ALA LYS ASN GLU MET SEQRES 16 A 407 ASN ALA TYR PHE SER ASP LEU ILE GLY LEU ARG SER ASP SEQRES 17 A 407 SER ALA GLY GLU ASP VAL THR SER LEU LEU GLY ALA ALA SEQRES 18 A 407 VAL GLY ARG ASP GLU ILE THR LEU SER GLU ALA VAL GLY SEQRES 19 A 407 LEU ALA VAL LEU LEU GLN ILE GLY GLY GLU ALA VAL THR SEQRES 20 A 407 ASN ASN SER GLY GLN MET PHE HIS LEU LEU LEU SER ARG SEQRES 21 A 407 PRO GLU LEU ALA GLU ARG LEU ARG SER GLU PRO GLU ILE SEQRES 22 A 407 ARG PRO ARG ALA ILE ASP GLU LEU LEU ARG TRP ILE PRO SEQRES 23 A 407 HIS ARG ASN ALA VAL GLY LEU SER ARG ILE ALA LEU GLU SEQRES 24 A 407 ASP VAL GLU ILE LYS GLY VAL ARG ILE ARG ALA GLY ASP SEQRES 25 A 407 ALA VAL TYR VAL SER TYR LEU ALA ALA ASN ARG ASP PRO SEQRES 26 A 407 GLU VAL PHE PRO ASP PRO ASP ARG ILE ASP PHE GLU ARG SEQRES 27 A 407 SER PRO ASN PRO HIS VAL SER PHE GLY PHE GLY PRO HIS SEQRES 28 A 407 TYR CYS PRO GLY GLY MET LEU ALA ARG LEU GLU SER GLU SEQRES 29 A 407 LEU LEU VAL ASP ALA VAL LEU ASP ARG VAL PRO GLY LEU SEQRES 30 A 407 LYS LEU ALA VAL ALA PRO GLU ASP VAL PRO PHE LYS LYS SEQRES 31 A 407 GLY ALA LEU ILE ARG GLY PRO GLU ALA LEU PRO VAL THR SEQRES 32 A 407 TRP ALA ALA ALA
HET HEM A 430 43 HET FLV A 431 15 HET FLV A 432 15 HET OXY A 433 2
HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM FLV FLAVIOLIN HETNAM OXY OXYGEN MOLECULE
HETSYN HEM HEME HETSYN FLV 2,5,7-TRIHYDROXYNAPHTHOQUINONE
FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 FLV 2(C10 H6 O5) FORMUL 5 OXY O2 FORMUL 6 HOH *258(H2 O)
HELIX 1 1 ASP A 27 GLY A 37 1 11 HELIX 2 2 ARG A 56 ASN A 65 1 10 HELIX 3 3 ARG A 71 MET A 75 5 5 HELIX 4 4 ALA A 92 LEU A 96 5 5 HELIX 5 5 ASP A 97 SER A 107 1 11 HELIX 6 6 VAL A 108 THR A 113 1 6 HELIX 7 7 THR A 113 ARG A 119 1 7 HELIX 8 8 VAL A 120 GLY A 139 1 20 HELIX 9 9 LEU A 144 VAL A 148 1 5 HELIX 10 10 SER A 150 GLY A 162 1 13 HELIX 11 11 PRO A 164 THR A 166 5 3 HELIX 12 12 ASP A 167 LEU A 179 1 13 HELIX 13 13 VAL A 187 LEU A 205 1 19 HELIX 14 14 ASP A 213 ARG A 224 1 12 HELIX 15 15 THR A 228 GLU A 244 1 17 HELIX 16 16 GLU A 244 ARG A 260 1 17 HELIX 17 17 ARG A 260 GLU A 270 1 11 HELIX 18 18 ILE A 273 ILE A 285 1 13 HELIX 19 19 SER A 317 ASN A 322 1 6 HELIX 20 20 GLY A 355 ARG A 373 1 19 HELIX 21 21 ALA A 382 VAL A 386 5 5
SHEET 1 A 6 VAL A 13 ASP A 15 0 SHEET 2 A 6 VAL A 39 SER A 43 1 O SER A 43 N ARG A 14 SHEET 3 A 6 ALA A 51 VAL A 54 -1 O LEU A 53 N THR A 40 SHEET 4 A 6 ALA A 313 VAL A 316 1 O TYR A 315 N TRP A 52 SHEET 5 A 6 ARG A 295 ALA A 297 -1 N ARG A 295 O VAL A 314 SHEET 6 A 6 PHE A 69 GLY A 70 -1 N GLY A 70 O ILE A 296 SHEET 1 B 3 ALA A 142 ASP A 143 0 SHEET 2 B 3 PRO A 401 THR A 403 -1 O VAL A 402 N ALA A 142 SHEET 3 B 3 LYS A 378 LEU A 379 -1 N LYS A 378 O THR A 403 SHEET 1 C 2 VAL A 301 ILE A 303 0 SHEET 2 C 2 VAL A 306 ILE A 308 -1 O ILE A 308 N VAL A 301
LINK FE HEM A 430 SG CYS A 353 1555 1555 2.32 LINK FE HEM A 430 O2 OXY A 433 1555 1555 1.90 LINK FE HEM A 430 O1 OXY A 433 1555 1555 2.74
SITE 1 AC1 23 ARG A 71 VAL A 93 GLY A 94 HIS A 101 SITE 2 AC1 23 ARG A 105 PHE A 112 LEU A 239 GLY A 242 SITE 3 AC1 23 GLY A 243 LEU A 282 HIS A 287 ARG A 295 SITE 4 AC1 23 TYR A 318 SER A 345 PHE A 346 HIS A 351 SITE 5 AC1 23 CYS A 353 PRO A 354 ALA A 359 FLV A 431 SITE 6 AC1 23 OXY A 433 HOH A 503 HOH A 680 SITE 1 AC2 13 ARG A 71 ARG A 288 GLY A 292 LEU A 293 SITE 2 AC2 13 HEM A 430 FLV A 432 OXY A 433 HOH A 503 SITE 3 AC2 13 HOH A 529 HOH A 537 HOH A 545 HOH A 564 SITE 4 AC2 13 HOH A 664 SITE 1 AC3 12 ILE A 87 PRO A 88 ILE A 241 ARG A 288 SITE 2 AC3 12 GLY A 292 LEU A 393 FLV A 431 HOH A 528 SITE 3 AC3 12 HOH A 545 HOH A 607 HOH A 664 HOH A 747 SITE 1 AC4 4 GLY A 242 HEM A 430 FLV A 431 HOH A 529
CRYST1 55.000 70.935 102.950 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018182 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014097 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009713 0.00000